Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure

Creative Commons License

Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A., Sahin D. Y., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.20, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20
  • Basım Tarihi: 2014
  • Doi Numarası: 10.12659/msm.889767
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.